Abstract: An apparatus has a first attribute setting unit which sets first attribute information of image data, a second attribute setting unit which sets second attribute information of the image data, and an input-output controller which writes and reads out image data to and from an external storage medium. The first attribute information is stored in the image data, and the second attribute information is stored in an area in the external storage medium, which is used to manage the image data to be written in the external storage medium.

Abstract: An image processing apparatus that records image data on a detachable storage medium in a previously set recording format is provided. The apparatus sets the recording format of image data, and determines whether or not a storage medium attached to an attachment unit has a communication function that communicates with a different apparatus than the image processing apparatus. If it is determined that the storage medium has a communication function, and that the recording format of image data that can be transferred by the communication function does not match the recording format that has been set, the apparatus issues a warning.

Abstract: An apparatus has a first attribute setting unit which sets first attribute information of image data, a second attribute setting unit which sets second attribute information of the image data, and an input-output controller which writes and reads out image data to and from an external storage medium. The first attribute information is stored in the image data, and the second attribute information is stored in an area in the external storage medium, which is used to manage the image data to be written in the external storage medium.

Abstract: The present invention relates to a pyrimidine derivative of the formula (I) and salts thereof which is useful as an active ingredient of pharmaceutical preparations. The pyrimidine derivative of the present invention has excellent CRTH2 (G-protein-coupled chemoattractant receptor, expressed on Th2 cells) antagonistic activity and can be used for the prophylaxis and treatment of diseases associated with CRTH2 activity, in particular for the treatment of allergic diseases, such as asthma, allergic rhinitis, atopic dermatitis, and allergic conjunctivitis; eosinophil-related diseases, such as Churg-Strauss syndrome and sinusitis; basophil-related diseases, such as basophilic leukemia, chronic urticaria and basophilic leukocytosis in human and other mammals; and inflammatory diseases characterized by T lymphocytes and profuse leukocyte infiltrates such as psoriasis, eczema, inflammatory bowel disease, ulcerative colitis, Crohn's disease, COPD (chronic obstructive pulmonary disorder) and arthritis.

Abstract: The present invention relates to a pyrimidine derivative of the formula (I) and salts thereof which is useful as an active ingredient of pharmaceutical preparations. The pyrimidine derivative of the present invention has excellent CRTH2 (G-protein-coupled chemoattractant receptor, expressed on Th2 cells) antagonistic activity and can be used for the prophylaxis and treatment of diseases associated with CRTH2 activity, in particular for the treatment of allergic diseases, such as asthma, allergic rhinitis, atopic dermatitis, and allergic conjunctivitis; eosinophil-related diseases, such as Churg-Strauss syndrome and sinusitis; basophil-related diseases, such as basophilic leukemia, chronic urticaria and basophilic leukocytosis in human and other mammals; and inflammatory diseases characterized by T lymphocytes and profuse leukocyte infiltrates such as psoriasis, eczema, inflammatory bowel disease, ulcerative colitis, Crohn's disease, COPD (chronic obstructive pulmonary disorder) and arthritis.

Abstract: The present invention relates to a sulfonamide derivative which is useful as an active ingredient of pharmaceutical preparations. The sulfonamide derivatives of the present invention have CCR3 (CC type chemokine receptor) antagonistic activity, and can be used for the prophylaxis and treatment of diseases associated with CCR3 activity, in particular for the treatment of asthma, atopic dermatitis, allergic rhinitis and other inflammatory/immunological disorders.

Abstract: The present invention relates to an imidazo[1,2-c]pyrimidinylacetic acid derivative and salts thereof which is useful as an active ingredient of pharmaceutical preparations.

Abstract: The present invention relates to a sulfonamide derivative which is useful as an active ingredient of pharmaceutical preparations. The sulfonamide derivatives of the present invention have CCR3 (CC type chemokine receptor) antagonistic activity, and can be used for the prophylaxis and treatment of diseases associated with CCR3 activity, in particular for the treatment of asthma, atopic dermatitis, allergic rhinitis and other inflammatory/immunological disorders.

Abstract: An image processing apparatus comprising: a foreign substance information acquisition unit which acquires, from input moving image data, foreign substance information containing a position and size of a foreign substance adhering to an optical element arranged in front of an image sensor in an image capturing apparatus that captures the moving image data; a motion vector information acquisition unit which acquires, from the moving image data, a motion vector of a macroblock obtained by dividing the moving image data; a correction playback unit which corrects deterioration of image quality caused by the foreign substance, based on the foreign substance information, and plays back moving image data; and a determination unit which determines, based on a motion vector of a macroblock matching the position of the foreign substance in the moving image data to be played back, whether to perform foreign substance correction playback of the macroblock.

Abstract: Foreign substance information including information on a position and size of a foreign substance in an imaging unit is acquired. When correcting a shadow of the foreign substance of the moving image data using the acquired foreign substance information and playing back the corrected moving image data, a selection is made whether to perform processing for correcting the shadow of the foreign substance of a frame based on the data size of the frame of the moving image data to be played back.

Abstract: An image processing apparatus includes an input unit which receives, from an image capturing apparatus, moving image data in which the shadow of a foreign substance adhered to the surface of an optical member is captured, an obtaining unit which obtains, from the moving image data, foreign substance information including information of the position and size of the foreign substance captured in the moving image data, a playback unit which can play back the moving image data while correcting the shadow of the foreign substance in the moving image data by using the foreign substance information, a display unit which displays an image played back by the playback unit, and a setting unit which sets, in accordance with the playback status of the moving image data, whether to perform processing of correcting the shadow of the foreign substance in each frame of the moving image data.

Abstract: The image sensing/playback apparatus has an image sensing device that senses an image of an object and obtains electrical image data, an input/output I/F that inputs/outputs image data from/to an external storage medium, and a system controller that sequentially performs a plurality of tasks, exclusively controlling the input/output I/F and having respective priorities decided in advance, while giving an opportunity to switch between the plurality of tasks after processing of one unit data amount of data. The one unit data amount is one of the first unit data amount that is large and the second unit data amount that is smaller than the first unit data amount.

Abstract: The present invention relates to an imidazo[1,2-c]pyrimidinylacetic acid derivative and salts thereof which is useful as an active ingredient of pharmaceutical preparations.

Abstract: Pyrimidine compounds of general formula: wherein —R1 represents in which R11 is hydrogen, C1-6 alkyl, halogen, hydroxy, C1-12 alkoxy, nitro, amino, C1-6 alkylsulfonylamino, C1-6 alkoxycarbonyl, C1-6 alkylamino, di (C1-6 alkyl)amino, C1-6 alkanoylamino, phenyl C1-6 alkylamino, phenylsulfonylamino, or —O—(CH2)n—R111; R2 represents hydrogen or halogen; R3 represents hydrogen, —CR31R32R33; R4 is hydrogen, carbamoyl, CN, carboxyl, etc.; R5 is amino, C1-6 alkylamino, di C1-6 alkylamino, etc. or salt thereof. The compound has an excellent anti-inflammatory activity, and other biological activity.

Abstract: 4-aryl pyrimidine compounds of general formula and salts thereof: wherein X is CH or N; R1 is hydrogen, halogen, C1-6 alkyl, C1-6 alkoxy, etc.; R2 is hydrogen or hydroxy; R3 is hydrogen, C1-6 alkyl, etc.; R4 is hydrogen, hydroxy, halogen, amino, etc.; R5 is hydroxy, amino, carboxy, etc.; R6 is hydrogen, carbamoyl, cyano, carboxy, C1-6 alkoxycarbonyl, etc. and R7 is amino or C1-6 alkanoylamino. The compounds (I) or the salts thereof have an excellent anti-inflammatory activity and the like.

Abstract: An apparatus has a first attribute setting unit which sets first attribute information of image data, a second attribute setting unit which sets second attribute information of the image data, and an input-output controller which writes and reads out image data to and from an external storage medium. The first attribute information is stored in the image data, and the second attribute information is stored in an area in the external storage medium, which is used to manage the image data to be written in the external storage medium.

Abstract: This invention is to provide a process for producing 2-amino-4,6-disubstituted nicotinic acid ester analogs and salts thereof, comprising the reaction shown by the following scheme. The ester analogs can be prepared in one pot, and in good yield by using tertiary alkyl cyanoacetate. Furthermore, the method is useful for preparing derivatives of various analogs of the ester, e.g. alkyl substituted and aryl substituted analogs.

Abstract: The present invention relates to a pyrimidine derivative of the formula (I) and salts thereof which is useful as an active ingredient of pharmaceutical preparations. The pyrimidine derivative of the present invention has excellent CRTH2 (G-protein-coupled chemoattractant receptor, expressed on Th2 cells) antagonistic activity and can be used for the prophylaxis and treatment of diseases associated with CRTH2 activity, in particular for the treatment of allergic diseases, such as asthma, allergic rhinitis, atopic dermatitis, and allergic conjunctivitis; eosinophil-related diseases, such as Churg-Strauss syndrome and sinusitis; basophil-related diseases, such as basophilic leukemia, chronic urticaria and basophilic leukocytosis in human and other mammals; and inflammatory diseases characterized by T lymphocytes and profuse leukocyte infiltrates such as psoriasis, eczema, inflammatory bowel disease, ulcerative colitis, Crohn's disease, COPD (chronic obstructive pulmonary disorder) and arthritis.

Abstract: This invention relates to aryl or heteroaryl amido alkane derivatives of formula (I) in which Ar1 and Ar2 independently represent phenyl or a 5 or 6-membered heteroaromatic ring, R6 represents carboxyl or tetrazolyl, and the remaining variables are as defined in the text and claims, which are useful as an active ingredient of pharmaceutical preparations. The aryl or heteroaryl amido alkanes of the present invention have PGI2 antagonistic activity, and can be used for the prophylaxis and treatment of diseases associated with PGI2 activity.

Abstract: Pyrimidine compounds of general formula: wherein —R1 represents in which R11 is hydrogen, C1-6 alkyl, halogen, hydroxy, C1-12 alkoxy, nitro, amino, C1-6 alkylsulfonylamino, C1-6 alkoxycarbonyl, C1-6 alkylamino, di (C1-6 alkyl)amino, C1-6 alkanoylamino, phenyl C1-6 alkylamino, phenylsulfonylamino, or —O—(CH2)n—R111; R2 represents hydrogen or halogen; R3 represents hydrogen, —CR31R32R33; R4 is hydrogen, carbamoyl, CN, carboxyl, etc.; R5 is amino, C1-6 alkylamino, di C1-6 alkylamino, etc. or salt thereof. The compound has an excellent anti-inflammatory activity, and other biological activity.